Analytical Data
-
Gene name
PRSS33
- Application
-
Alternative Names
PRSS33；Serine protease 33
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NF86
-
Expression Region
23-280aa
-
AA Sequence
RKSAACGQ PRMSSRIVGG RDGRDGEWPW QASIQHRGAH VCGGSLIAPQ WVLTAAHCFP RRALPAEYRV RLGALRLGST SPRTLSVPVR RVLLPPDYSE DGARGDLALL QLRRPVPLSA RVQPVCLPVP GARPPPGTPC RVTGWGSLRP GVPLPEWRPL QGVRVPLLDS RTCDGLYHVG ADVPQAERIV LPGSLCAGYP QGHKDACQGD SGGPLTCLQS GSWVLVGVVS WGKGCALPNR PGVYTSVATY SPWIQARVSF
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PRSS33, a member of the serine protease family, has garnered attention due to its potential roles in various physiological and pathological processes. Initially identified in humans, PRSS33 is expressed predominantly in the pancreas and has been implicated in digestive functions, although its specific substrates and biological functions remain largely unexplored. Recent studies suggest that PRSS33 may also play a role in immune response and inflammation, potentially influencing conditions such as pancreatitis and other pancreatic disorders. The interest in PRSS33 has intensified as researchers aim to elucidate its structural characteristics, enzymatic activity, and regulatory mechanisms. Recombinant expression of PRSS33 offers a valuable platform for these investigations, allowing for detailed studies on its activity and interactions with other cellular components. By harnessing recombinant protein technology, scientists can produce PRSS33 in sufficient quantities to perform biochemical assays and structural analyses, ultimately contributing to a better understanding of its functional roles in health and disease. The findings from such research could have significant implications for therapeutic approaches to pancreatic diseases and broaden our understanding of the serine protease family's contributions to human health.
